Coldstream Capital Management Inc Catalent, Inc. Transaction History

Coldstream Capital Management Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$44.2 - $50.2 $269,266 - $305,818	6,092 New	6,092 $277,000
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $47,484 - $77,601	1,045 Added 21.5%	5,906 $388,000
Q4 2022 Jan 10, 2023	SELL	$41.39 - $81.0 $7,905 - $15,471	-191 Reduced 3.78%	4,861 $0
Q2 2022 Aug 08, 2022	BUY	$87.2 - $114.05 $257,152 - $336,333	2,949 Added 140.23%	5,052 $542,000
Q2 2022 Aug 08, 2022	SELL	$87.2 - $114.05 $85,979 - $112,453	-986 Reduced 31.92%	2,103 $226,000
Q1 2022 May 11, 2022	SELL	$94.19 - $124.49 $113,875 - $150,508	-1,209 Reduced 28.13%	3,089 $343,000
Q4 2021 Feb 11, 2022	BUY	$119.57 - $139.07 $143,603 - $167,023	1,201 Added 38.78%	4,298 $550,000
Q3 2021 Nov 12, 2021	SELL	$109.17 - $142.35 $11,681 - $15,231	-107 Reduced 3.34%	3,097 $265,000
Q2 2021 Aug 16, 2021	BUY	$100.34 - $115.69 $11,238 - $12,957	112 Added 3.62%	3,204 $347,000
Q1 2021 Jun 16, 2021	BUY	$101.51 - $125.27 $5,380 - $6,639	53 Added 1.74%	3,092 $325,000
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $3,521 - $4,319	41 Added 1.37%	3,039 $317,000
Q3 2020 Nov 16, 2020	SELL	$72.74 - $92.5 $53,463 - $67,987	-735 Reduced 19.69%	2,998 $257,000
Q2 2020 Aug 12, 2020	SELL	$48.02 - $79.04 $41,009 - $67,500	-854 Reduced 18.62%	3,733 $274,000
Q1 2020 May 27, 2020	BUY	$36.95 - $62.95 $169,489 - $288,751	4,587 New	4,587 $239,000
Q4 2018 Feb 26, 2019	SELL	$29.95 - $46.34 $134,565 - $208,205	-4,493 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$40.12 - $45.55 $180,259 - $204,656	4,493 New	4,493 $205,000

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Coldstream Capital Management Inc with notifications on news.